Treviamet®
Therapeutic Segment:
Anti-Diabetic
Generic Name:
Sitagliptin phosphate monohydrate + Metformin HCl
Indication
Tablets
- 50MG + 1000MG
- 50MG + 500MG
As an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus who are already treated with metformin alone or who are not adequately controlled on metformin alone, or for those patients who have initially responded to metformin and require additional glycemic control.